Table of Contents
Ulcers
Volume 2010, Article ID 163804, 11 pages
http://dx.doi.org/10.1155/2010/163804
Review Article

Possible Association between Th1 Immune Polarization and Epithelial Permeability with Toll-Like Receptors 2 Dysfunction in the Pathogenesis of the Recurrent Aphthous Ulceration

1São Leopoldo Mandic Dental Research Institute, Campinas, SP 03316-000, Brazil
2Dental School, University Nove de Julho, SP, Brazil

Received 2 November 2009; Accepted 12 February 2010

Academic Editor: Tetsuo Arakawa

Copyright © 2010 Fabiana M. Barros et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Scully and S. Porter, “Oral mucosal disease: recurrent aphthous stomatitis,” The British Journal of Oral and Maxillofacial Surgery, vol. 46, no. 3, pp. 198–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. McCullough, S. Abdel-Hafeth, and C. Scully, “Recurrent aphthous stomatitis revisited; clinical features, associations, and new association with infant feeding practices?” Journal of Oral Pathology and Medicine, vol. 36, no. 10, pp. 615–620, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. R. I. E. Lake, S. J. Thomas, and N. G. Martin, “Genetic factors in the aetiology of mouth ulcers,” Genetic Epidemiology, vol. 14, no. 1, pp. 17–33, 1997. View at Google Scholar · View at Scopus
  4. A. L. S. Guimaraes, J. d. F. Correia-Silva, A. R. Sa et al., “Investigation of functional gene polymorphisms IL-1ß, IL-6, IL-10 and TNF-a in individuals with recurrent aphthous stomatitis,” Archives of Oral Biology, vol. 52, no. 3, pp. 268–272, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. R. Bazrafshani, A. H. Hajeer, W. E. R. Ollier, and M. H. Thornhill, “IL-1B and IL-6 gene polymorphisms encode significant risk for the development of recurrent aphthous stomatitis (RAS),” Genes and Immunity, vol. 3, no. 5, pp. 302–305, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. N. Victoria, J. D. F. Correia-Silva, F. J. Pimenta, E. Kalapothakis, and R. S. Gomez, “Serotonin transporter gene polymorphism (5-HTTLPR) in patients with recurrent aphthous stomatitis,” Journal of Oral Pathology and Medicine, vol. 34, no. 8, pp. 494–497, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Shohat-Zabarski, S. Kalderon, T. Klein, and A. Weinberger, “Close association of HLA-B51 in persons with recurrent aphthous stomatitis,” Oral Surgery Oral Medicine and Oral Pathology, vol. 74, no. 4, pp. 455–458, 1992. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Weinberger, “Human lymphocyte antigen (HLA) B51 is more frequent in patients with recurrent aphthous stomatitis (RAS),” Clinical and Experimental Rheumatology, vol. 15, no. 1, pp. 118–119, 1997. View at Google Scholar · View at Scopus
  9. L. Jaber, A. Weinberger, T. Klein, I. Yaniv, and M. Mukamel, “Close association of HLA-B52 and HLA-B44 antigens in Israeli Arab adolescents with recurrent aphthous stomatitis,” Archives of Otolaryngology—Head & Neck Surgery, vol. 127, no. 2, pp. 184–187, 2001. View at Google Scholar · View at Scopus
  10. R. C. Borra, P. M. Andrade, I. D. Silva et al., “The Th1/Th2 immune-type response of the recurrent aphthous ulceration analyzed by cDNA microarray,” Journal of Oral Pathology and Medicine, vol. 33, no. 3, pp. 140–146, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Freysdottir, S. Zhang, W. M. Tilakaratne, and F. Fortune, “Oral biopsies from patients with orofacial granulomatosis with histology resembling Crohn's disease have a prominent Th1 environment,” Inflammatory Bowel Diseases, vol. 13, no. 4, pp. 439–445, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Garside, A. Mc. I. Mowat, and A. Khoruts, “Oral tolerance in disease,” Gut, vol. 44, no. 1, pp. 137–142, 1999. View at Google Scholar · View at Scopus
  13. A. K. Chakrabarty, S. Mraz, J. K. Geisse, and N. J. Anderson, “Aphthous ulcers associated with imiquimod and the treatment of actinic cheilitis,” Journal of the American Academy of Dermatology, vol. 52, no. 2, supplement 1, pp. S35–S37, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Zalaudek, G. Petrillo, and G. Argenziano, “Aphthous ulcers and imiquimod,” Journal of the American Academy of Dermatology, vol. 53, no. 2, pp. 360–361, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Monteleone, F. Pallone, and G. Monteleone, “Interleukin-23 and Th17 cells in the control of gut inflammation,” Mediators of Inflammation, vol. 2009, Article ID 297645, 7 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Albanidou-Farmaki, A. K. Markopoulos, F. Kalogerakou, and D. Z. Antoniades, “Detection, enumeration and characterization of T helper cells secreting type 1 and type 2 cytokines in patients with recurrent aphthous stomatitis,” Tohoku Journal of Experimental Medicine, vol. 212, no. 2, pp. 101–105, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. N. T. Miyamoto Jr., R. C. Borra, M. Abreu, L. L. M. Weckx, and M. Franco, “Immune-expression of HSP27 and IL-10 in recurrent aphthous ulceration,” Journal of Oral Pathology and Medicine, vol. 37, no. 8, pp. 462–467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. I. J. Buno, J. C. Huff, W. L. Weston, D. T. Cook, and S. L. Brice, “Elevated levels of interferon gamma, tumor necrosis factor α, interleukins 2, 4, and 5, but not interleukin 10, are present in recurrent aphthous stomatitis,” Archives of Dermatology, vol. 134, no. 7, pp. 827–831, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Lewkowicz, P. Lewkowicz, M. Banasik, A. Kurnatowska, and H. Tchorzewski, “Predominance of type 1 cytokines and decreased number of CD4+CD25+high T regulatory cells in peripheral blood of patients with recurrent aphthous ulcerations,” Immunology Letters, vol. 99, no. 1, pp. 57–62, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Calcagni and I. Elenkov, “Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases,” Annals of the New York Academy of Sciences, vol. 1069, pp. 62–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Maes, A. Christophe, E. Bosmans, A. Lin, and H. Neels, “In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress,” Biological Psychiatry, vol. 47, no. 10, pp. 910–920, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Buske-Kirschbaum, S. Kern, M. Ebrecht, and D. H. Hellhammer, “Altered distribution of leukocyte subsets and cytokine production in response to acute psychosocial stress in patients with psoriasis vulgaris,” Brain, Behavior, and Immunity, vol. 21, no. 1, pp. 92–99, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Wahle, G. Hanefeld, S. Brunn et al., “Failure of catecholamines to shift T-cell cytokine responses toward a Th2 profile in patients with rheumatoid arthritis,” Arthritis Research and Therapy, vol. 8, no. 5, article R138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. D. E. Griswold, L. M. Hillegass, J. J. Breton, K. M. Esser, and J. L. Adams, “Differentiation in vivo of classical non-steroidal antiinflammatory drugs from cytokine suppressive antiinflammatory drugs and other pharmacological classes using mouse tumour necrosis factor alpha production,” Drugs under Experimental and Clinical Research, vol. 19, no. 6, pp. 243–248, 1993. View at Google Scholar · View at Scopus
  25. I. Tsuboi, H. Tanaka, M. Nakao, S. Shichijo, and K. Itoh, “Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-gamma and IL-2, in contrast to down-regulation of IL-6 production,” Cytokine, vol. 7, no. 4, pp. 372–379, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Barth, A. Guseo, and R. Klein, “In vitro study on the immunological effect of bromelain and trypsin on mononuclear cells from humans,” European Journal of Medical Research, vol. 10, no. 8, pp. 325–331, 2005. View at Google Scholar · View at Scopus
  27. D. Guggi and A. Bernkop-Schnurch, “Improved paracellular uptake by the combination of different types of permeation enhancers,” International Journal of Pharmaceutics, vol. 288, no. 1, pp. 141–150, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Manni and G. J. M. Maestroni, “Sympathetic nervous modulation of the skin innate and adaptive immune response to peptidoglycan but not lipopolysaccharide: involvement of β-adrenoceptors and relevance in inflammatory diseases,” Brain, Behavior, and Immunity, vol. 22, no. 1, pp. 80–88, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Lacarrubba, M. R. Nasca, and G. Micali, “Advances in the use of topical imiquimod to treat dermatologic disorders,” Therapeutics and Clinical Risk Management, vol. 4, no. 1, pp. 87–97, 2008. View at Google Scholar · View at Scopus
  30. M. Peracchi, F. Bamonti Catena, M. Pomati, M. De Franceschi, and G. Scalabrino, “Human cobalamin deficiency: alterations in serum tumour necrosis factor-α and epidermal growth factor,” European Journal of Haematology, vol. 67, no. 2, pp. 123–127, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Roubenoff, R. A. Roubenoff, J. Selhub et al., “Abnormal vitamin B6 status in rheumatoid cachexia. Association with spontaneous tumor necrosis factor alpha production and markers of inflammation,” Arthritis and Rheumatism, vol. 38, no. 1, pp. 105–109, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. C. A. Whetzel, E. J. Corwin, and L. C. Klein, “Disruption in Th1/Th2 immune response in young adult smokers,” Addictive Behaviors, vol. 32, no. 1, pp. 1–8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. G. L. Torres de Heens, R. Kikkert, L. A. Aarden, U. van der Velden, and B. G. Loos, “Effects of smoking on the ex vivo cytokine production in periodontitis,” Journal of Periodontal Research, vol. 44, no. 1, pp. 28–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. G. S. Madretsma, G. J. Donze, A. P. M. van Dijk, C. J. Tak, J. H. P. Wilson, and F. J. Zijlstra, “Nicotine inhibits the in vitro production of interleukin 2 and tumour necrosis factor-α by human mononuclear cells,” Immunopharmacology, vol. 35, no. 1, pp. 47–51, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. J. R. Challis, C. J. Lockwood, L. Myatt, J. E. Norman, J. F. Strauss III, and F. Petraglia, “Inflammation and pregnancy,” Reproductive Sciences, vol. 16, no. 2, pp. 206–215, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Brugman, J. T. J. Visser, J. L. Hillebrands, N. A. Bos, and J. Rozing, “Prolonged exclusive breastfeeding reduces autoimmune diabetes incidence and increases regulatory T-cell frequency in bio-breeding diabetes-prone rats,” Diabetes/Metabolism Research and Reviews, vol. 25, no. 4, pp. 380–387, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. L. G. Corral, P. A. J. Haslett, G. W. Muller et al., “Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha,” International Journal of Leprosy and Other Mycobacterial Diseases, vol. 163, no. 1, pp. 380–386, 1999. View at Google Scholar
  38. D. R. Moller, M. Wysocka, B. M. Greenlee et al., “Inhibition of IL-12 production by thalidomide,” Journal of Immunology, vol. 159, no. 10, pp. 5157–5161, 1997. View at Google Scholar · View at Scopus
  39. I. Ricciardelli, K. J. Lindley, M. Londei, and S. Quaratino, “Anti tumour necrosis-α therapy increases the number of FOXP3 + regulatory T cells in children affected by Crohn's disease,” Immunology, vol. 125, no. 2, pp. 178–183, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Toubi, A. Kessel, Z. Mahmudov, K. Hallas, M. Rozenbaum, and I. Rosner, “Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab,” Annals of the New York Academy of Sciences, vol. 1051, pp. 506–514, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Bienvenu, C. Doche, M.-C. Gutowski, M. Lenoble, A. Lepape, and J.-P. Perdrix, “Production of proinflammatory cytokines and cytokines involved in the TH1/TH2 balance is modulated by pentoxifylline,” Journal of Cardiovascular Pharmacology, vol. 25, supplement 2, pp. S80–S84, 1995. View at Google Scholar
  42. E. Cario, “Barrier-protective function of intestinal epithelial Toll-like receptor 2,” Mucosal Immunology, vol. 1, supplement 1, pp. S62–S66, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. J. A. Ship, E. M. Chavez, P. A. Doerr, B. S. Henson, and M. Sarmadi, “Recurrent aphthous stomatitis,” Quintessence International, vol. 31, no. 2, pp. 95–112, 2000. View at Google Scholar · View at Scopus
  44. A. Jacobi, D. Debus, G. Schuler, and M. Hertl, “Infliximab in a patient with refractory mucosal aphthosis,” Journal of the European Academy of Dermatology and Venereology, vol. 22, no. 1, pp. 109–110, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. N. D. Robinson and J. Guitart, “Recalcitrant, recurrent aphthous stomatitis treated with etanercept,” Archives of Dermatology, vol. 139, no. 10, pp. 1259–1262, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Sanchez-Cano, J. L. Callejas-Rubio, R. Ruiz-Villaverde, and N. Ortego-Centeno, “Recalcitrant, recurrent aphthous stomatitis successfully treated with adalimumab,” Journal of the European Academy of Dermatology and Venereology, vol. 23, no. 2, article 206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. R. C. Borra, F. de Mesquita Barros, M. de Andrade Lotufo, F. E. Villanova, and P. M. Andrade, “Toll-like receptor activity in recurrent aphthous ulceration,” Journal of Oral Pathology and Medicine, vol. 38, no. 3, pp. 289–298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Takeda and S. Akira, “Toll-like receptors in innate immunity,” International Immunology, vol. 17, no. 1, pp. 1–14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Qi, T. L. Denning, and L. Soong, “Differential induction of interleukin-10 and interleukin-12 in dendritic cells by microbial Toll-like receptor activators and skewing of T-cell cytokine profiles,” Infection and Immunity, vol. 71, no. 6, pp. 3337–3342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Re and J. L. Strominger, “IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells,” Journal of Immunology, vol. 173, no. 12, pp. 7548–7555, 2004. View at Google Scholar · View at Scopus
  51. S. Dillon, A. Agrawal, T. Van Dyke et al., “A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells,” Journal of Immunology, vol. 172, no. 8, pp. 4733–4743, 2004. View at Google Scholar · View at Scopus
  52. N. Novak, J. Haberstok, T. Bieber, and J.-P. Allam, “The immune privilege of the oral mucosa,” Trends in Molecular Medicine, vol. 14, no. 5, pp. 191–198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Palazzo, S. Gariboldi, L. Zanobbio et al., “Cross-talk among Toll-like receptors and their ligands,” International Immunology, vol. 20, no. 5, pp. 709–718, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. M. G. Netea, B. J. Kullberg, D. J. de Jong et al., “NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease,” European Journal of Immunology, vol. 34, no. 7, pp. 2052–2059, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. T. K. Ghosh, D. J. Mickelson, J. C. Solberg, K. E. Lipson, J. R. Inglefield, and S. S. Alkan, “TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-α,” International Immunopharmacology, vol. 7, no. 8, pp. 1111–1121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. R. J. Dearman, M. Cumberbatch, G. Maxwell, D. A. Basketter, and I. Kimber, “Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells,” Immunology, vol. 126, no. 4, pp. 475–484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. R. P. M. Sutmuller, M. H. den Brok, M. Kramer et al., “Toll-like receptor 2 controls expansion and function of regulatory T cells,” Journal of Clinical Investigation, vol. 116, no. 2, pp. 485–494, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Liu, M. Komai-Koma, D. Xu, and F. Y. Liew, “Toll-like receptor 2 signaling modulates the functions of CD4+CD25+ regulatory T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 18, pp. 7048–7053, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. N. Lewkowicz, P. Lewkowicz, K. Dzitko et al., “Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis,” Journal of Oral Pathology and Medicine, vol. 37, no. 8, pp. 454–461, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Abdollahi-Roodsaz, L. A. B. Joosten, M. I. Koenders et al., “Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis,” Journal of Clinical Investigation, vol. 118, no. 1, pp. 205–216, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. F. V. Loures, A. Pina, M. Felonato, and V. L. Calich, “TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection,” Journal of Immunology, vol. 183, no. 2, pp. 1279–1290, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Zanin-Zhorov, L. Cahalon, G. Tal, R. Margalit, O. Lider, and I. R. Cohen, “Heat shock protein 60 enhances CD4+CD25+ regulatory T cell function via innate TLR2 signaling,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 2022–2032, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. A. G. Pockley, M. Muthana, and S. K. Calderwood, “The dual immunoregulatory roles of stress proteins,” Trends in Biochemical Sciences, vol. 33, no. 2, pp. 71–79, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Hasan, T. Shinnick, Y. Mizushima, R. van der Zee, and T. Lehner, “Defining a T-cell epitope within HSP 65 in recurrent aphthous stomatitis,” Clinical and Experimental Immunology, vol. 128, no. 2, pp. 318–325, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Hasan, A. Childerstone, K. Pervin et al., “Recognition of a unique peptide epitope of the mycobacterial and human heat shock protein 65-60 antigen by T cells of patients with recurrent oral ulcers,” Clinical and Experimental Immunology, vol. 99, no. 3, pp. 392–397, 1995. View at Google Scholar · View at Scopus
  66. C. Habich and V. Burkart, “Heat shock protein 60: regulatory role on innate immune cells,” Cellular and Molecular Life Sciences, vol. 64, no. 6, pp. 742–751, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. A. Zanin-Zhorov, R. Bruck, G. Tal et al., “Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines,” Journal of Immunology, vol. 174, no. 6, pp. 3227–3236, 2005. View at Google Scholar · View at Scopus
  68. J. A. G. van Roon, W. van Eden, J. L. van Roy, F. J. Lafeber, and J. W. J. Bijlsma, “Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat-shock protein in synovial fluid of patients with rheumatoid arthritis,” Journal of Clinical Investigation, vol. 100, no. 2, pp. 459–463, 1997. View at Google Scholar · View at Scopus
  69. F. J. Quintana, A. Mimran, P. Carmi, F. Mor, and I. R. Cohen, “HSP60 as a target of anti-ergotypic regulatory T cells,” PLoS One, vol. 3, no. 12, article e4026, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. E. Cario, G. Gerken, and D. K. Podolsky, “Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C,” Gastroenterology, vol. 127, no. 1, pp. 224–238, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Chen, J. N. Rao, T. Zou et al., “Polyamines are required for expression of Toll-like receptor 2 modulating intestinal epithelial barrier integrity,” American Journal of Physiology, vol. 293, no. 3, pp. G568–G576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Uchida, H. Shiba, H. Komatsuzawa et al., “Irsogladine maleate influences the response of gap junctional intercellular communication and IL-8 of human gingival epithelial cells following periodontopathogenic bacterial challenge,” Biochemical and Biophysical Research Communications, vol. 333, no. 2, pp. 502–507, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Kojima, M. Murata, M. Go, D. C. Spray, and N. Sawada, “Connexins induce and maintain tight junctions in epithelial cells,” Journal of Membrane Biology, vol. 217, no. 1–3, pp. 13–19, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. Y. Nanke, N. Kamatani, T. Okamoto, H. Ogiuchi, and S. Kotake, “Irsogladine is effective for recurrent oral ulcers in patients with Behcet's disease: an open-label, single-centre study,” Drugs in R & D, vol. 9, no. 6, pp. 455–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Hara, T. Murata, R. Uemura et al., “Identification of connexins in human oral mucosa and therapeutic effect of irsogladine maleate on aphthous stomatitis,” Journal of Gastroenterology, vol. 34, no. 1, pp. 1–6, 1999. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Yoshida and M. Hirakata, “Therapeutic benefits of irsogladine maleate on aphthous stomatitis induced by methotrexate in rheumatoid arthritis,” Journal of Rheumatology, vol. 30, no. 9, pp. 2082–2083, 2003. View at Google Scholar · View at Scopus
  77. A. S. Tang, P. J. Chikhale, P. K. Shah, and R. T. Borchardt, “Utilization of a human intestinal epithelial cell culture system (Caco-2) for evaluating cytoprotective agents,” Pharmaceutical Research, vol. 10, no. 11, pp. 1620–1626, 1993. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Rattan, M. Schneider, N. Arber, M. Gorsky, and D. Dayan, “Sucralfate suspension as a treatment of recurrent aphthous stomatitis,” Journal of Internal Medicine, vol. 236, no. 3, pp. 341–343, 1994. View at Google Scholar · View at Scopus
  79. T. Matsuda, S. Ohno, S. Hirohata et al., “Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behcet's disease: a randomised, double-blind, placebo-controlled study,” Drugs in R & D, vol. 4, no. 1, pp. 19–28, 2003. View at Publisher · View at Google Scholar · View at Scopus
  80. T. Suzuki, N. Yoshida, N. Nakabe et al., “Prophylactic effect of rebamipide on aspirin-induced gastric lesions and disruption of tight junctional protein zonula occludens-1 distribution,” Journal of Pharmacological Sciences, vol. 106, no. 3, pp. 469–477, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. L. Chahine, N. Sempson, and C. Wagoner, “The effect of sodium lauryl sulfate on recurrent aphthous ulcers: a clinical study,” Compendium of Continuing Education in Dentistry, vol. 18, no. 12, pp. 1238–1240, 1997. View at Google Scholar · View at Scopus
  82. B. B. Herlofson and P. Barkvoll, “The effect of two toothpaste detergents on the frequency of recurrent aphthous ulcers,” Acta Odontologica Scandinavica, vol. 54, no. 3, pp. 150–153, 1996. View at Google Scholar · View at Scopus
  83. B. B. Herlofson and P. Barkvoll, “Oral mucosal desquamation caused by two toothpaste detergents in an experimental model,” European Journal of Oral Sciences, vol. 104, no. 1, pp. 21–26, 1996. View at Google Scholar · View at Scopus
  84. J. A. Nicolazzo, B. L. Reed, and B. C. Finnin, “Assessment of the effects of sodium dodecyl sulfate on the buccal permeability of caffeine and estradiol,” Journal of Pharmaceutical Sciences, vol. 93, no. 2, pp. 431–440, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. S. S. Natah, R. Hayrinen-Immonen, J. Hietanen, M. Malmstrom, and Y. T. Konttinen, “Factor XIIIa-positive dendrocytes are increased in number and size in recurrent aphthous ulcers (RAU),” Journal of Oral Pathology and Medicine, vol. 26, no. 9, pp. 408–413, 1997. View at Google Scholar · View at Scopus
  86. C. W. Cutler and R. Jotwani, “Dendritic cells at the oral mucosal interface,” Journal of Dental Research, vol. 85, no. 8, pp. 678–689, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. J.-P. Allam, G. Stojanovski, N. Friedrichs et al., “Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy?” Allergy, vol. 63, no. 6, pp. 720–727, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Freysdottir, S.-H. Lau, and F. Fortune, “γδ T cells in Behcet's disease (BD) and recurrent aphthous stomatitis (RAS),” Clinical and Experimental Immunology, vol. 118, no. 3, pp. 451–457, 1999. View at Publisher · View at Google Scholar · View at Scopus
  89. S. S. Natah, R. Hayrinen-Immonen, J. Hietanen et al., “Increased density of lymphocytes bearing ?/d T-cell receptors in recurrent aphthous ulceration (RAU),” International Journal of Oral and Maxillofacial Surgery, vol. 29, no. 5, pp. 375–380, 2000. View at Google Scholar · View at Scopus
  90. C. L. Roark, P. L. Simonian, A. P. Fontenot, W. K. Born, and R. L. O'Brien, “γδ T cells: an important source of IL-17,” Current Opinion in Immunology, vol. 20, no. 3, pp. 353–357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. S. R. Carding and P. J. Egan, “The importance of γδT cells in the resolution of pathogen-induced inflammatory immune responses,” Immunological Reviews, vol. 173, pp. 98–108, 2000. View at Publisher · View at Google Scholar · View at Scopus
  92. M. I. Hirsh, N. Hashiguchi, Y. Chen, L. Yip, and W. G. Junger, “Surface expression of HSP72 by LPS-stimulated neutrophils facilitates γδT cell-mediated killing,” European Journal of Immunology, vol. 36, no. 3, pp. 712–721, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. H. K. Komori, T. F. Meehan, and W. L. Havran, “Epithelial and mucosal γδ T cells,” Current Opinion in Immunology, vol. 18, no. 5, pp. 534–538, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. A. A. Kuhl, N. N. Pawlowski, K. Grollich, C. Loddenkemper, M. Zeitz, and J. C. Hoffmann, “Aggravation of intestinal inflammation by depletion/deficiency of γδ T cells in different types of IBD animal models,” Journal of Leukocyte Biology, vol. 81, no. 1, pp. 168–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. V. Kunzmann, B. Kimmel, T. Herrmann, H. Einsele, and M. Wilhelm, “Inhibition of phosphoantigen-mediated γδ T-cell proliferation by CD4+CD25+ FoxP3+ regulatory T cells,” Immunology, vol. 126, no. 2, pp. 256–267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. K. Marakoglu, R. E. Sezer, H. C. Toker, and I. Marakoglu, “The recurrent aphthous stomatitis frequency in the smoking cessation people,” Clinical Oral Investigations, vol. 11, no. 2, pp. 149–153, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. I. Berlin, “Endocrine and metabolic effects of smoking cessation,” Current Medical Research and Opinion, vol. 25, no. 2, pp. 527–534, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. J. J. Malago, J. F. J. G. Koninkx, and J. E. van Dijk, “The heat shock response and cytoprotection of the intestinal epithelium,” Cell Stress and Chaperones, vol. 7, no. 2, pp. 191–199, 2002. View at Google Scholar · View at Scopus
  99. M. Maes, D. R. Van Bockstaele, A. van Gastel et al., “The effects of psychological stress on leukocyte subset distribution in humans: evidence of immune activation,” Neuropsychobiology, vol. 39, no. 1, pp. 1–9, 1999. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Buske-Kirschbaum, M. Ebrecht, S. Kern, and D. H. Hellhammer, “Endocrine stress responses in TH1-mediated chronic inflammatory skin disease (psoriasis vulgaris)—do they parallel stress-induced endocrine changes in TH2-mediated inflammatory dermatoses (atopic dermatitis)?” Psychoneuroendocrinology, vol. 31, no. 4, pp. 439–446, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. D. M. Nance and V. M. Sanders, “Autonomic innervation and regulation of the immune system (1987–2007),” Brain, Behavior, and Immunity, vol. 21, no. 6, pp. 736–745, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. K. Vakharia and J. P. Hinson, “Lipopolysaccharide directly stimulates cortisol secretion by human adrenal cells by a cyclooxygenase-dependent mechanism,” Endocrinology, vol. 146, no. 3, pp. 1398–1402, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. S. R. Bornstein, P. Zacharowski, R. R. Schumann et al., “Impaired adrenal stress response in Toll-like receptor 2-deficient mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 47, pp. 16695–16700, 2004. View at Publisher · View at Google Scholar · View at Scopus
  104. E. Gulcan, S. Toker, H. Hatipoglu, A. Gulcan, and A. Toker, “Cyanocobalamin may be beneficial in the treatment of recurrent aphthous ulcers even when vitamin B12 levels are normal,” American Journal of the Medical Sciences, vol. 336, no. 5, pp. 379–382, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. I. Volkov, I. Rudoy, T. Freud et al., “Effectiveness of vitamin B12 in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial,” Journal of the American Board of Family Medicine, vol. 22, no. 1, pp. 9–16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. L. L. N. Husemoen, U. Toft, M. Fenger, T. Jorgensen, N. Johansen, and A. Linneberg, “The association between atopy and factors influencing folate metabolismml: is low folate status causally related to the development of atopy?” International Journal of Epidemiology, vol. 35, no. 4, pp. 954–961, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. Y. Ozkan, S. Yardim-Akaydin, A. Sepici, B. Engin, V. Sepici, and B. Simsek, “Assessment of homocysteine, neopterin and nitric oxide levels in Behcet's disease,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 1, pp. 73–77, 2007. View at Publisher · View at Google Scholar · View at Scopus
  108. A. Finamore, M. Massimi, L. C. Devirgiliis, and E. Mengheri, “Zinc deficiency induces membrane barrier damage and increases neutrophil transmigration in Caco-2 cells,” Journal of Nutrition, vol. 138, no. 9, pp. 1664–1670, 2008. View at Google Scholar · View at Scopus
  109. T. A. Mikhailov and S. E. Furner, “Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children,” World Journal of Gastroenterology, vol. 15, no. 3, pp. 270–279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. F. Guarner, R. Bourdet-Sicard, P. Brandtzaeg et al., “Mechanisms of disease: the hygiene hypothesis revisited,” Nature Clinical Practice Gastroenterology and Hepatology, vol. 3, no. 5, pp. 275–284, 2006. View at Publisher · View at Google Scholar · View at Scopus
  111. C. Vanderpool, F. Yan, and D. B. Polk, “Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases,” Inflammatory Bowel Diseases, vol. 14, no. 11, pp. 1585–1596, 2008. View at Publisher · View at Google Scholar · View at Scopus